Introduction
============

Hypoxic-ischemic encephalopathy (HIE), secondary to perinatal asphyxia, is a primary cause of pediatric mortality and morbidity, and results in neurologic outcomes, such as cerebral palsy, mental retardation and epilepsy ([@b1-etm-0-0-3740]). Timely prognostic information is important in counseling parents and in determining the appropriate level of treatment. Consequently, reliable early examinations are urgently required. During the last decade, advances have been achieved in the field of diagnosis and prognosis of HIE ([@b2-etm-0-0-3740]).

Clinicians use prognostic tests, including magnetic resonance (MR) imaging (MRI), to help determine the prognosis and decide whether to consider treatment withdrawal. It is understood that MRI serves an increasing important role for imaging the neonatal brain ([@b3-etm-0-0-3740]--[@b6-etm-0-0-3740]). However, proton MR spectroscopy has been developed for clinical use. This allows real-time analyses of the metabolites in the human brain. It has been widely reported that the potential utility of proton MR spectroscopy could reveal brain ischemic injuries in asphyxiated neonates earlier than T1- or T2-weighted MR imaging ([@b7-etm-0-0-3740]--[@b11-etm-0-0-3740]). Whether MR spectroscopy prior to conventional MR imaging should be used in the early diagnosis of neonate with HIE remains unknown. How to select the imaging technique between the two methods in different conditions? Therefore, the aim of the present study was to evaluate the value of MR spectroscopy and MR imaging for the diagnosis of HIE.

Subjects and methods
====================

### Subject selection

The protocol was approved by the review board of Nanjing Medical University (Nanjing, China). Participants in the study were voluntary; the study was performed after obtaining informed consent from the infants\' parents. In this study, 24 full term infants (17 males, 7 females; age range,0--15 days) with HIE were collected from the Department of Pediatrics in Huai\'an First People\'s Hospital Affiliated to Nanjing Medical University (Huai\'an, China) between February 2012 and February 2013. All of the cases had perinatal asphyxia, and were defined as having at least three of the following criteria ([@b12-etm-0-0-3740]): i) Fetal heart rate abnormalities; ii) meconium staining of amniotic fluid; iii) delayed onset of respiration; iv) early postnatal blood pH level \<7.1; v) Apgar score at 5 min of \<5; or vi) multiorgan failure. Furthermore, all neonates had signs of neonatal encephalopathy ([@b13-etm-0-0-3740]).

Neonates with congenital malformation, trauma, metabolic or infective diseases, and patients born prior to reaching a 36-week gestational age, were excluded from this study. Five healthy term infants (3 males, 2 females; age range, 0--15 days) were recruited in the control group. The patients underwent MRI examination for scalp hematoma or slight neonatal jaundice.

### MRI examinations

During the MRI procedures, all neonates were sedated with chloral hydrate 10 mg/kg (Sigma-Aldrich, St. Louis, MO, USA) orally, or rectally as a suppository. Vacuum pillows were used to prevent patients movement during MR examinations. Ear protection to noise exposure was provided by using neonatal ear muffs. A pediatrician was present throughout the investigation. The neonates were monitored by MR-compatible pulse oximetry during the examination procedure. For those neonates with severe encephalopathy who were in a coma or who were ventilator-dependent, hand-bag ventilator equipment was used.

All images in these series were obtained with superconducting magnets (MAGNETOM Avanto; Siemens Healthcare GmbH, Erlangen, Germany) operating at a field-strength of 1.5T magnet. All infants were in the axial plane. The total duration of the examination is 8 min.

### Conventional MRI methods

MRI protocols included 4.0 mm transverse and sagittal T1-weighted spin-echo sequences \[repetition time (TR)/echo time (TE), 468/11 and 400/8.1 ms, respectively\]; 4.0 mm transverse T2-weighted fast spin-echo sequence (TR/TE, 4000/101 ms); and an echo-planar imaging technique was used for diffusion weighted imaging (DWI; repetition time msec/echo time msec = 3300/93), with a 180×180 mm field of view, 4.0 mm section thickness and b values of 0 and 1,000 sec/mm^2^.

### Proton MR spectroscopy methods

MR spectroscopy was performed similarly to the routine MR protocol. Spectra were acquired by using a single-voxel technique to select a single volume of interest (voxel dimensions, 10 mm^3^, 1 ml) in the left or right basal ganglia and thalamus, as reported previously. The basal ganglia and thalamus are most sensitive to the effects of acute anoxia ([@b14-etm-0-0-3740]). This single voxel can reflect the global disturbances, such as cortical gray matter and the frontal and occipital white matter. Placement was performed carefully to avoid contact with cerebral spinal fluid.

The parameters of single-voxel MR spectroscopy were as follows: TR, 1,500 ms; TE, 35 ms; 128 signals acquired; and 8NEX. Water suppression was achieved by applying chemical shift selective saturation pulses. Metabolites of biologic importance, such as N-acetylaspartate (NAA), creatine (Cr), and choline (Cho) peaks were identified at 2.02, 3.02 and 3.24 ppm, respectively. When present, lactate (Lac) was identified as a doublet at 1.33 ppm.

Automated curve was performed on an MRI operator console by using proprietary software (Siemens Healthcare GmbH). Manual phase adjustment was applied if necessary. In all cases, peak surface area was used to calculate metabolite ratios for metabolite quantification. As for Lac, the combined area under the doublet was used for calculations.

### Conventional MRI

The MR images obtained in all neonates were analyzed independently by a senior radiologist (Dr. Dehang Wang) who was experienced in neonatal neuroimaging, blinded to the clinical outcomes and MR spectroscopy information, and who analyzed the images according to MRI scores ([@b15-etm-0-0-3740]). This score (range, 0--22; [Table I](#tI-etm-0-0-3740){ref-type="table"}) was generated according to a report on MRI and DWI abnormalities in neonates with HIE ([@b16-etm-0-0-3740]). The following predefined structures were analyzed: Basal ganglia regions (including thalamus); cerebral cortex; periventricular and subcortical white matter; corpus callosum; and brainstem. For each structure, any MR signal intensity abnormality irrelevant to injury was documented as a high-signal intensity (SI) lesion on T1 weighted image (WI).

### MR spectroscopy quantifications

The spectra was reviewed by an MR specialist (Dr. Genji Bo) who had 10 years of experience in interpreting brain MR spectroscopy and who was blinded to the clinical outcomes and the MR images. All ^1^H-MR spectroscopic data were included in the analysis (n=29) and all findings were pooled. Cr was used as a reference to measure the ratios of NAA/Cr, Cho/Cr and Lac/Cr. These ratios were compared in the 29 neonates to select a perspective indicator of the neonates with HIE.

### Statistical analysis

Data obtained were expressed as the mean ± standard deviation, and all data were analyzed using SPSS version 15.0 statistical software (SPSS, Inc., Chicago, IL, USA). P\<0.05 were considered to indicate a statistically significant difference. The comparison between the control and HIE group was performed by a two-tailed t-test. The paired comparisons among the control group and each HIE group were performed by two-way analysis of variance and the Student-Newman-Keuls method.

Results
=======

### Clinical characteristics

The neurologic examinations were routinely performed by the pediatricians in charge of the neonates. Knowledge of the outcomes, including seizures, sensory impairment and encephalodysplasia, were collected from the medical records by these pediatricians.

Two cases with severe HIE succumbed to irreversible cerebral injury and withdrawal of the life-sustaining treatments. The decision to withdraw treatment was based on the combination results of clinical examination, cerebral MRI, ^1^H-MR spectroscopy and electroencephalography, as reported previously ([@b17-etm-0-0-3740]). The remaining cases received suitable HIE treatment. The average number of days spent in hospital were as follows: Mild to moderate group, 11.5 days (range, 6--18 days); severe group, 19.6 days (range, 8--25 days). Four cases of severe HIE neonates still had weak nerve reaction upon discharge from the hospital. The neurological system symptoms of the remaining participants disappeared prior to leaving the hospital. No abnormal nervous system signs were detected in the control group.

Neonatal HIE severity was graded clinically according to Sarnat-Sarnat classification ([@b18-etm-0-0-3740]). The general condition of the HIE neonates were as follows ([Table II](#tII-etm-0-0-3740){ref-type="table"}): Mild to moderate (stages I--II), 13 cases; severe (stage III), 11 cases.

### MR imaging data

According to the MRI data, abnormal imaging was not identified in the control group. Four types of images in HIE groups were observed. Cerebral hyperintensity lesions (according to the site of lesions, two subtypes could be detected), cortex and/or watershed area lesions ([Fig. 1](#f1-etm-0-0-3740){ref-type="fig"}) and periventricular white matter lesions ([Fig. 2](#f2-etm-0-0-3740){ref-type="fig"}) were detected. These characteristic abnormalities were visible as early as the first day of life. However, these lesions identified by punctuate hypersignal on T1WI and hyposignal on T2WI were assumed to be petechial hemorrhage, gliotic scarring, scarring or mineralization, which are impossible to distinguish on T1- and T2WI ([@b19-etm-0-0-3740],[@b20-etm-0-0-3740]). Longitudinal imaging showed a decrease in the number of punctate white matter lesions (PWML) over time, without hypersignal of PWML on T1WI, suggesting hemorrhage; a number of PWML did not change hypersignal on T1WI, suggesting early gliosis ([@b21-etm-0-0-3740]). In addition, basal ganglia, thalamic, corpus callosum or mesencephalic injury ([Fig. 3](#f3-etm-0-0-3740){ref-type="fig"}) was identified on conventional and diffusion-weighted MR images. Furthermore, subarachnoid haemorrhage, in which short T1 high signal was manifested in the posterior sagittal sinus, horizontal sinus, cerebellar tentorium or confluence of sinus ([Fig. 4](#f4-etm-0-0-3740){ref-type="fig"}), was detected. Finally, intraventricular haemorrhage ([Fig. 5](#f5-etm-0-0-3740){ref-type="fig"}) could be observed.

Compared with the images of the two HIE groups, punctate hyperintensity lesions on T1WI in the cortex or subcortical white matter and brain edema on T2WI were visually similar. Abnormal SI of the thalamus, corpus callosum or brain stem on conventional and diffusion-weighted MR images were significantly different in the severe group (P=0.001). Abnormal SI within the basal ganglia and thalami may predict the severity outcome.

Unilateral parenchymal hemorrhage was identified in four infants in the HIE group. The mean number of PWML in the mild to moderate group (stages I--II) was 5.38±4.68 (range, 1--13). The mean number of PWML in the severe group (stage III) was 16.82±17.66 (range, 4--59). A significant difference was identified between these two groups in regard to the number of PWML (P=0.035). The majority of PWML were identified close to the medullary veins and showed restricted diffusion on early MRI; two infants did not have restricted diffusion on early MRI (identified as hyposignal on DWI).

The neonatal MR score was obtained from the scan images. Points were awarded for the presence of brain swelling and abnormal SI within the cortex, subcortical and periventricular white matter, basal ganglia and thalamus, brain stem, and from the posterior limb of the internal capsule. The MR scores ([Table III](#tIII-etm-0-0-3740){ref-type="table"}) of the two HIE groups were compared. The mean MR imaging score was 6.20±1.75 for cases of stage I--II and 9.78±3.64 for cases of stage III. There was a significant difference between the two groups (P=0.009).

MR spectroscopy. In the control and HIE groups, the peaks of metabolites of biologic importance, such as NAA (2.02 ppm), Cr (3.02 ppm) and Cho (3.24 ppm), were identified. The Cr was used as a reference to measure NAA/Cr, Cho/Cr and Lac/Cr ratios ([Table IV](#tIV-etm-0-0-3740){ref-type="table"}). In the control group, the values of NAA/Cr and Cho/Cr were 1.60±0.47 and 1.67±0.81, respectively, while Lac/Cr was not detected. In the HIE groups, Lac was identified as a doublet at 1.33 ppm, and the values of NAA/Cr, Cho/Cr and Lac/Cr were 1.09±0.4, 2.12±0.87 and 0.14±0.26, respectively. In the mild to moderate group (stages I--II), the ratios showed NAA/Cr of 1.23±0.35, Cho/Cr of 1.84±0.37 and Lac/Cr of 0.03±0.06. In the severe group (stage III), the ratios showed NAA/Cr of 0.97±0.41, Cho/Cr of 2.43±1.16 and Lac/Cr of 0.26±0.34.

Between control and HIE groups, the differences of NAA/Cr, Cho/Cr and Lac/Cr in the basal ganglia and thalamus were statistically significant (P\<0.05). Multiple comparisons were performed among control and HIE groups ([Table V](#tV-etm-0-0-3740){ref-type="table"}). The differences of NAA/Cr, Cho/Cr and Lac/Cr between the control and mild to moderate groups, and control and severe groups, were statistically significant (P\<0.05). The differences of NAA/Cr, Cho/Cr and Lac/Cr between mild to moderate and severe groups was not statistically significant (P\>0.05).

Discussion
==========

MR imaging technology, which is thought to show brain morphology at a high resolution in the clinic, has been developed rapidly in the past decades. It is superior to cerebral CT and ultrasound examination in displaying lesions in the basal ganglia or deep white matter, and multi-cystic encephalomalacia around the ventricle ([@b22-etm-0-0-3740]).

T1WI could provide essential information for the diagnosis and depicting typical MRI features of hypoxic-ischemic injury ([@b3-etm-0-0-3740],[@b5-etm-0-0-3740]--[@b6-etm-0-0-3740]). The imaging pattern of HIE has been classified into three types ([@b4-etm-0-0-3740],[@b23-etm-0-0-3740]); parasagittal lesions, involving cortico-subcortical regions, profound lesions located in the basal ganglia or thalamus, and multi-cystic encephalomalacia. Parasagittal lesions are typically associated with milder HIE ([@b24-etm-0-0-3740]). In the present study, the T1 images in the mild to moderate (n=13) and severe group (n=11) were similar, with punctate hyperintensity in the cortex or subcortical white matter (P\>0.05). Profound lesions in the basal ganglia and thalamus are often associated with serious HIE ([@b25-etm-0-0-3740]). The results in the present study showed unequivocally that lesions in the basal ganglia and thalamus were associated with the severe group. Finally, multi-cystic encephalomalacia are typically connected with an end-stage finding of severe HIE. Multiple cysts in the brain were not detected in the current study.

Previously, a meta-analysis ([@b14-etm-0-0-3740]) reported the prognostic utilities of various quantitative cerebral MR biomarkers in neonatal encephalopathy. Thirty-two studies were included that were performed between January 1990 and July 2008. Regarding predicting adverse outcome, T1WIs during the first 30 days had a pooled sensitivity of 91% (95% confidence interval \[CI\], 87--94%). The pattern of injury identified with T1WI may provide diagnostic and prognostic information for neonatal encephalopathy ([@b20-etm-0-0-3740],[@b14-etm-0-0-3740]). Infants who show abnormal SI in the basal ganglia/thalami typically undergo an adverse outcome ([@b12-etm-0-0-3740]--[@b26-etm-0-0-3740]). The changes in routine T1WIs are characteristic, but a question is put forward as to whether MRS biomarkers may be available in T1WI in the evaluation of infants.

MRS is a non-invasive technique that allows real-time analysis of metabolites in the human brain ([@b27-etm-0-0-3740]). Cho is a marker for membrane synthesis and Cr (3.0 ppm) is chosen as the reference because of its stability. Due to the rapid growth of the membranes in the neonatal brain, the NAA (2.01 ppm) level is much lower than Cho (3.02 ppm) ([@b28-etm-0-0-3740]). Reportedly, Lac (1.33 ppm) is not present in great quantities in normal neonates and is rarely detected by MRS ([@b11-etm-0-0-3740]). In the present study, Lac in the control group was not observed.

The ascent of Lac/Cr, presumably because of energy failure and the necessity to metabolize glucose anaerobically, was not marked as elucidated by Hanrahan *et al* ([@b12-etm-0-0-3740]), in contrast to the results of the present study. It seems likely that this difference of results is related to the time of the MRS examination with respect to the hypoxic-ischemic event. The mean time from injury to MRS in patients in the current study was 7 days; for patients in Hanrahan *et al* ([@b12-etm-0-0-3740]), the mean time was \<24 h. The precise time at which lactate levels become lower after hypoxic-ischemic injury in neonates is unknown. Indeed, in the study by Xu and Vigneron ([@b29-etm-0-0-3740]), although the presence of lactate persisted, the Lac level always dropped on follow-up spectra performed weeks after the injury. Hence, it can be suggested that the Lac level would have been higher if the patients had been studied earlier following perinatal hypoxic-ischaemic injury in the present study. The results in the present study were consistent with those of Barkovich *et al* ([@b30-etm-0-0-3740]) and Alderliesten *et al* ([@b31-etm-0-0-3740]), who found associations with NAA levels in HIE. Similarly, the patients in the study by Barkovich *et al* ([@b30-etm-0-0-3740]) experienced injury within an average of 7 days prior to MRS and those of Alderliesten *et al* ([@b31-etm-0-0-3740]) experienced a hypoxic-ischemic event at an average of 6 days. Surprisingly, no statistically significant differences in NAA/Cr and Lac/Cr were identified between the mild to moderate and severe group. In comparison with MR performances, results of proton MRS had a number of limitations in distinguishing mild from moderate to severe injury.

In conclusion, ^1^H-MRS is a useful technique for distinguishing between HIE and normal newborns; however, with regard to differentiating between grades, ^1^H-MRS should be interpreted in conjunction with performances on T1WI.

![(A) Mild hypoxic-ischemic encephalopathy neonate at 3 days of age; transverse T1 weighted image showed subcortical punctate hyperintensity. (B) Magnetic resonance spectroscopy (1500/35 ms) images of the basal ganglia; low levels of N-acetylaspartate were detected.](etm-12-05-2835-g00){#f1-etm-0-0-3740}

![(A) Moderate hypoxic-ischemic encephalopathy neonate at 24 days of age. Transverse T1 weighted image showed multiple punctate hyperintensity surrounding the ventricle. (B) Magnetic resonance spectroscopy (1500/35 ms) images of the basal ganglia; low levels of N-acetylaspartate were detected.](etm-12-05-2835-g01){#f2-etm-0-0-3740}

![(A) Severe hypoxic-ischemic encephalopathy neonate at 1 day of age. Transverse T1 weighted image showed multiple punctate hyperintensity surrounding the ventricle and low-signal-intensity areas on the corpus callosum. (B) Magnetic resonance spectroscopy (1500/35 ms) images of the basal ganglia; low levels of N-acetylaspartate were detected.](etm-12-05-2835-g02){#f3-etm-0-0-3740}

![(A) Mild hypoxic-ischemic encephalopathy neonate at 14 days of age; transverse T1 weighted image showed subarachnoid hemorrhage. (B) Magnetic resonance spectroscopy (1500/35 ms) images of the basal ganglia; low levels of N-acetylaspartate were detected.](etm-12-05-2835-g03){#f4-etm-0-0-3740}

![(A) Mild hypoxic-ischemic encephalopathy neonate at 8 days of age. Transverse T1 weighted image showed subarachnoid and intraventricular hemorrhage. (B) Magnetic resonance spectroscopy (1500/35 ms) images of the basal ganglia; low levels of N-acetylaspartate were detected.](etm-12-05-2835-g04){#f5-etm-0-0-3740}

###### 

Magnetic resonance imaging score criteria.

  Category   Score criteria
  ---------- -----------------------------------------------------------------------------------------------------------------------
  A          Brain swelling: 0, Not present; 2, present
  B          Grey/white matter differentiation: 0, Present; 1, absent in one localization; 2, absent in more than one localization
  C          High signal in the posterior limb of the internal capsule on T1WI: 0, Normal; 1, mild decrease; 2, absent
  D          Hyperintensity on T1WI sequences on PP and T: 0, None; 1, one localization; 2, more than one localization
  E          Hyperintensity on T2 sequences on PP and T: 0, None; 1, one localization; 2, more than one localization
  F          Brain stem abnormalities on T1WI and/or T2WI sequences: 0, None; 1, present
  G          Cortex abnormalities on T1 and/or T2 sequences: 0, None; 1, one localization; 2, more than one localization
  H          White matter petechial abnormalities: 0, None; 1, one localization; 2, more than one localization
  I          Subarachnoid hemorrhages: 0, None; 1, present
  J          White-matter abnormalities in DWI: 0, None; 1, one localization; 2, more than one localization
  K          Basal ganglia abnormalities in DWI: 0, None; 1, one localization; 2, more than one localization
  L          Cerebral cortex abnormalities in DWI: 0, None; 1, one localization; 2, more than one localization

T1WI, T1 weighted image; T2WI, T2 weighted image; DWI, diffusion weighted imaging; PP, putamen and pallidum; T, thalamus.

###### 

Clinical data and magnetic resonance findings of all participants in the study.

  Case no.   Gender   Age (days)   Number of PWML   Signal on DWI (reduced diffusion)   Body weight (g)   Outcome
  ---------- -------- ------------ ---------------- ----------------------------------- ----------------- ---------------------------------
    1        M        3            4                Yes                                 3350              Minor or moderate abnormalities
    2        M        7            13               Yes                                 3000              Minor or moderate abnormalities
    3        M        1            0                No                                  3630              No abnormalities
    4        F        3            0                No                                  3070              No abnormalities
    5        M        15           0                No                                  3040              No abnormalities
    6        M        5            6                Yes                                 4000              Minor or moderate abnormalities
    7        M        10           8                No                                  3620              Minor or moderate abnormalities
    8        M        2            35               Yes                                 2380              Mortality on day 6
    9        F        3            13               Yes                                 3760              Severe abnormalities
  10         F        1            8                Yes                                 3510              Minor or moderate abnormalities
  11         M        3            1                Yes                                 2800              No abnormalities
  12         M        1            1                Yes                                 3710              No abnormalities
  13         M        3            12               Yes                                 3560              Minor or moderate abnormalities
  14         F        5            6                Yes                                 3450              No abnormalities
  15         M        1            0                Yes                                 2565              No abnormalities
  16         M        12           2                Yes                                 2570              Minor or moderate abnormalities
  17         F        11           20               Yes                                 2850              Severe abnormalities
  18         F        11           14               Yes                                 2560              Severe abnormalities
  19         M        8            2                Yes                                 4480              No abnormalities
  20         F        4            0                Yes                                 3100              No abnormalities
  21         M        1            24               Yes                                 3000              Severe abnormalities
  22         F        5            59               Yes                                 2050              Mortality on day 12
  23         M        8            1                Yes                                 3570              No abnormalities
  24         M        15           1                No                                  3450              No abnormalities
  25         M        3            1                Yes                                 2860              No abnormalities
  26         M        6            11               Yes                                 3600              Minor or moderate abnormalities
  27         M        10           5                Yes                                 4000              Minor or moderate abnormalities
  28         F        3            1                Yes                                 2850              No abnormalities
  29         M        2            13               Yes                                 3600              Minor or moderate abnormalities

PWML, punctate white matter lesions; DWI, diffusion weighted image; M, male; F, female.

###### 

Magnetic resonance scores for all participants.

        Category                                                    
  ----- ---------- --- --- --- --- --- --- --- --- --- --- --- ---- ------
    1   2          0   2   0   0   0   0   2   1   2   0   0   9    1--2
    2   2          0   2   0   0   0   0   2   0   2   0   0   8    1--2
    3   0          0   0   0   0   0   0   0   0   0   0   0   0    0
    4   0          0   0   0   0   0   0   0   0   0   0   0   0    0
    5   0          0   0   0   0   0   0   0   0   0   0   0   0    0
    6   0          0   1   0   0   0   0   2   1   2   0   0   5    3
    7   0          0   2   0   0   0   0   2   0   0   0   0   4    1--2
    8   2          0   2   0   0   0   0   2   0   2   2   0   10   3
    9   2          2   1   0   0   0   2   2   0   2   2   2   15   3
  10    0          0   2   0   0   0   0   2   0   2   0   0   6    1--2
  11    2          0   2   0   0   0   0   1   1   1   0   0   7    1--2
  12    2          1   2   0   0   0   0   1   0   1   0   0   6    1--2
  13    2          2   2   0   2   1   0   2   0   2   2   0   15   3
  14    2          0   2   0   0   0   2   2   1   2   0   2   13   3
  15    0          0   0   0   0   0   0   0   0   0   0   0   0    0
  16    0          0   1   0   0   0   0   2   0   2   0   0   5    1--2
  17    2          0   2   0   0   0   0   2   0   2   0   0   8    3
  18    0          0   0   0   0   0   2   2   1   2   0   2   9    3
  19    2          0   2   0   0   0   0   1   0   1   0   0   4    1--2
  20    0          0   0   0   0   0   0   0   0   0   0   0   0    0
  21    2          0   2   0   0   0   2   2   1   2   2   2   15   3
  22    2          0   0   0   0   0   1   2   0   2   0   1   8    3
  23    2          2   2   0   0   0   1   1   1   1   0   1   11   3
  24    2          2   2   0   0   0   0   1   1   1   0   0   9    3
  25    0          0   1   0   0   0   0   1   0   1   0   0   3    1--2
  26    2          0   1   0   0   0   0   2   0   2   0   0   7    1--2
  27    2          1   0   0   0   0   0   2   1   0   0   0   6    1--2
  28    2          2   2   0   0   0   0   1   0   1   0   0   8    1--2
  29    2          0   2   0   0   0   0   2   0   2   0   0   8    1--2

###### 

Quantitative analyses of the metabolic compounds used in the study.

  Groups             Number   NAA/Cr      Cho/Cr      Lac/Cr
  ------------------ -------- ----------- ----------- -----------
  Control              5      1.60±0.47   1.67±0.81   --
  HIE                24       1.09±0.41   2.12±0.87   0.14±0.26
  Mild to moderate   13       1.23±0.35   1.84±0.37   0.03±0.06
  Severe             11       0.97±0.41   2.43±1.16   0.26±0.34

Data was expressed as the mean ± standard deviation. HIE, hypoxic-ischemic encephalopathy; NAA, N-acetylaspartate; Cr, creatinine; Cho, choline; Lac, lactate.

###### 

Comparison of magnetic resonance spectroscopy metabolites between control and HIE groups.

  Groups                         NAA/Cr P   Cho/Cr P   Lac/Cr P
  ------------------------------ ---------- ---------- ----------
  Control vs. HIE                0.015      0.029      0.020
  Control vs. Mild to moderate   0.016      0.040      0.048
                                                       
  Control vs. severe             0.010      0.010      0.050
  Mild to moderate vs. severe    0.171      0.138      0.380

The t-test was used to compare the quantity of the metabolic compounds among the control and HIE groups. P\<0.05 was considered to indicate a statistically significant difference. HIE, hypoxic-ischemic encephalopathy; NAA, N-acetylaspartate; Cr, creatinine; Cho, choline; Lac, lactate; P, P-values.
